Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens

PLoS One. 2020 Jun 3;15(6):e0234119. doi: 10.1371/journal.pone.0234119. eCollection 2020.

Abstract

Recently, a new rapid assay for the detection of tcdB gene of Clostridioides difficile was developed using the GENECUBE. The assay can directly detect the tcdB gene from stool samples without a purification in approximately 35 minutes with a few minutes of preparation process. We performed a prospective comparative study of the performance of the assay at eight institutions in Japan. Fresh residual stool samples (Bristol stool scale ≥5) were used and comparisons were performed with the BD MAX Cdiff assay and toxigenic cultures. For the evaluation of 383 stool samples compared with the BD MAX Cdiff assay, the sensitivity, and specificity of the two assays was 99.0% (379/383), 98.1% (52/53), 99.1% (327/330), respectively. In the comparison with toxigenic culture, the total, sensitivity, and specificity were 96.6% (370/383), 85.0% (51/60), and 98.8% (319/323), respectively. The current investigation indicated the GENECUBE Clostridioides difficile assay has equivalent performance with the BD MAX Cdiff assay for the detection of tcdB gene of C. difficile.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Proteins / genetics*
  • Bacterial Toxins / genetics*
  • Clostridioides difficile / genetics*
  • Clostridioides difficile / isolation & purification
  • Clostridium Infections / diagnosis
  • DNA, Bacterial / genetics
  • DNA, Bacterial / metabolism
  • Enterotoxins / genetics
  • Feces / microbiology*
  • Humans
  • Polymerase Chain Reaction / methods
  • Reagent Kits, Diagnostic
  • Repressor Proteins / genetics
  • Sensitivity and Specificity

Substances

  • Bacterial Proteins
  • Bacterial Toxins
  • DNA, Bacterial
  • Enterotoxins
  • Reagent Kits, Diagnostic
  • Repressor Proteins
  • TcdC protein, Clostridium difficile
  • tcdA protein, Clostridium difficile
  • toxB protein, Clostridium difficile

Grants and funding

This study was supported by TOYOBO Co., Ltd. The funder provided support in the form of salaries to authors A. Sugiyama and Y. Kawashima, and lecture fees to authors H. Suzuki, and advisory fees to author H. Suzuki. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author contributions’ section.